# Nuclide record cyclopharm (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/cyclopharm/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "cyclopharm" ;
  schema:name "Cyclopharm"@en ;
  schema:alternateName "Cyclomedica"@en, "Cyclomedica Australia"@en, "Cyclopharm Limited"@en ;
  schema:description "The Australian company behind Technegas, the inhaled ventilation agent, which spent thirty years as a product the United States could not buy and is now being installed across American hospitals."@en ;
  schema:url <https://nuclide.cc/companies/cyclopharm/>, <https://www.cyclopharm.com/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://www.cyclomedica.com/company/cyclopharm/>, <https://investor.cyclopharm.com/site/pdf/ee402a7a-7ffe-4386-9541-9d22f3e60b42/Platform/ListPage/CYC-1H2026-Results-Summary.pdf>, <https://investor.cyclopharm.com/site/pdf/60334760-9465-4ad1-9ff3-1d17eb39d00c/Platform/ListPage/Immediate-11Site-Technegas-Rollout-at-University-Hospitals.pdf> ;
  nuclide:tag "ventilation", "Australia", "listed" ;
  schema:addressCountry "AU" ;
  nuclide:related <https://nuclide.cc/drugs/technegas/>, <https://nuclide.cc/indications/pulmonary-embolism-vq/>, <https://nuclide.cc/isotopes/tc-99m/> .